Similar articles

• [Retroperitoneal drainage for apostematous pyelonephritis in a patient with severe COVID-19 infection and diabetes mellitus type 1].

  Lobanov LS, Lobanov YS, Shapovalov KG, Lobanov SL, Filev AP. Lobanov LS, et al. Khirurgiia (Mosk). 2022;(1):90-92. doi: 10.17116/hirurgia202201190. Khirurgiia (Mosk). 2022. PMID: 35080833 Russian.
• COVID-19 and Type 2 Diabetes Mellitus: HCQ may be the Holy Grail.

  Pal R, Bhasin MK, Bhadada SK. Pal R, et al. Infect Disord Drug Targets. 2021;21(5):e270421186842. doi: 10.2174/1871526520666201013160803. Infect Disord Drug Targets. 2021. PMID: 33050869
• Tuberculosis and Type 2 Diabetes Mellitus: An Inflammatory Danger Signal in the Time of Coronavirus Disease 2019.

  Wilkinson RJ. Wilkinson RJ. Clin Infect Dis. 2021 Jan 23;72(1):79-81. doi: 10.1093/cid/ciaa747. Clin Infect Dis. 2021. PMID: 32533824 Free PMC article. No abstract available.
• COVID-19 and Diabetes.

  Singh AK, Khunti K. Singh AK, et al. Annu Rev Med. 2022 Jan 27;73:129-147. doi: 10.1146/annurev-med-042220-011857. Epub 2021 Aug 11. Annu Rev Med. 2022. PMID: 34379444 Review.
• Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients.

  Hasan SS, Kow CS, Bain A, Kavanagh S, Merchant HA, Hadi MA. Hasan SS, et al. Expert Opin Pharmacother. 2021 Feb;22(2):229-240. doi: 10.1080/14656566.2020.1837114. Epub 2020 Oct 22. Expert Opin Pharmacother. 2021. PMID: 33054481 Review.